Clinical Trials Browser

Unknown × Waldenstrom Macroglobulinemia × Rituximab × Clear all

NCT05979948 2023-09-14

CZ-WM01

Phase 2 Unknown

Waldenstrom Macroglobulinemia

NCT00397800 2012-08-28

Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma

Phase 1/2 Unknown

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell